JPRN-UMIN000009745
Recruiting
未知
High-sensitivity imaging of erlotinib in resected non-small-cell lung cancer - High-sensitivity imaging of erlotinib in resected non-small-cell lung cancer
Department of Internal Medicine Division of Medical Oncology & Respiratory Medicine Shimane University Faculty of Medicine0 sites1 target enrollmentStarted: January 10, 2013Last updated:
Overview
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Department of Internal Medicine Division of Medical Oncology & Respiratory Medicine Shimane University Faculty of Medicine
- Enrollment
- 1
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- ot applicable to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Case with serious complications
Investigators
Similar Trials
Recruiting
Not Applicable
Imaging of [11C]erlotinib pharmacokinetics in non small cell lung cancer patients; an in vivo study with positron emission tomographylung cancer10038666NL-OMON32923Vrije Universiteit Medisch Centrum10
Not yet recruiting
Phase 2
The Utility of PET/CT in Erlotinib treatment for Non-Small Cell canceron-small cell lung cancerJPRN-UMIN000002044Department of Respiratory Medicine, Allergy and Rheumatic Diseases, Osaka University Graduate School of Medicine20
Completed
Not Applicable
Serum marker analysis of Erlotinib treatment in previously treated Non-small cell lung cancer (NSCLC) patients with and without Epidermal Growth Factor Receptor (EGFR) mutation (additional study of CJLSG0903/0904)on-small cell lung cancerJPRN-UMIN000005754Central Japan Lung Study Group (CJLSG)83
Active, not recruiting
Not Applicable
MIMEB - Molecular Imaging with erlotinib and bevacizumab. A Phase II Clinical Trial to Evaluate the Accuracy of FDG-/FLT-PET and DCE-MRI for Early Prediction of Non-Progression in Patients with Advanced Non Squamous Cell Non Small Cell Lung Cancer (NSCLC) treated with Erlotinib and Bevacizumab and to Associate Imaging Findings with Molecular Markers - MIMEBEUCTR2009-012607-26-DEniversity of Cologne
Completed
Not Applicable
[11C]Erlotinib tumor heterogeneity: an in vivo study using static whole body positron emission tomography in non-small cell lung cancer patients.NL-OMON44987Vrije Universiteit Medisch Centrum30